K.U. Hunter

597 total citations
22 papers, 458 citations indexed

About

K.U. Hunter is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Radiation. According to data from OpenAlex, K.U. Hunter has authored 22 papers receiving a total of 458 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Otorhinolaryngology, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Radiation. Recurrent topics in K.U. Hunter's work include Head and Neck Cancer Studies (10 papers), Advanced Radiotherapy Techniques (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). K.U. Hunter is often cited by papers focused on Head and Neck Cancer Studies (10 papers), Advanced Radiotherapy Techniques (6 papers) and Hepatocellular Carcinoma Treatment and Prognosis (5 papers). K.U. Hunter collaborates with scholars based in United States and Australia. K.U. Hunter's co-authors include Avraham Eisbruch, Douglas B. Chepeha, Teresa Lyden, Felix Y. Feng, Matthew J. Schipper, Mathew J. Schipper, Shruti Jolly, C.S. Hamilton, Jonathan Wheat and James W. Denham and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Advances in experimental medicine and biology.

In The Last Decade

K.U. Hunter

21 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.U. Hunter United States 9 248 210 149 140 138 22 458
Robin Marsh United States 6 460 1.9× 360 1.7× 250 1.7× 231 1.6× 170 1.2× 9 663
Jean‐Briac Prévost Netherlands 8 323 1.3× 630 3.0× 198 1.3× 150 1.1× 544 3.9× 11 908
Bianca Vanstraelen Belgium 10 249 1.0× 348 1.7× 219 1.5× 78 0.6× 243 1.8× 15 588
Tara A. van de Water Netherlands 6 340 1.4× 411 2.0× 150 1.0× 92 0.7× 336 2.4× 6 625
Abrahim Al‐Mamgani Netherlands 15 403 1.6× 222 1.1× 266 1.8× 78 0.6× 93 0.7× 38 663
Giuseppina Gambaro Italy 12 248 1.0× 210 1.0× 114 0.8× 34 0.2× 145 1.1× 17 576
Anke Petra Jellema Netherlands 5 306 1.2× 230 1.1× 119 0.8× 23 0.2× 78 0.6× 6 425
Suzanne Rose United Kingdom 10 136 0.5× 190 0.9× 201 1.3× 183 1.3× 14 0.1× 14 434
Pushpa Patel United States 8 93 0.4× 122 0.6× 83 0.6× 15 0.1× 43 0.3× 12 279
Hui-Min Ting Taiwan 11 182 0.7× 214 1.0× 86 0.6× 8 0.1× 217 1.6× 16 429

Countries citing papers authored by K.U. Hunter

Since Specialization
Citations

This map shows the geographic impact of K.U. Hunter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.U. Hunter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.U. Hunter more than expected).

Fields of papers citing papers by K.U. Hunter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.U. Hunter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.U. Hunter. The network helps show where K.U. Hunter may publish in the future.

Co-authorship network of co-authors of K.U. Hunter

This figure shows the co-authorship network connecting the top 25 collaborators of K.U. Hunter. A scholar is included among the top collaborators of K.U. Hunter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.U. Hunter. K.U. Hunter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nugent, F. Warren, Amy E.B. Packard, K.U. Hunter, et al.. (2018). Economic analysis of transarterial chemoembolization (TACE) versus stereotactic body radiotherapy (SBRT) for the treatment of hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 36(4_suppl). 508–508. 4 indexed citations
4.
Nugent, F. Warren, Krishna S. Gunturu, Keith Stuart, et al.. (2017). A randomized phase II study of individualized stereotactic body radiation therapy (SBRT) versus transarterial chemoembolization (TACE) as a bridge to transplant in hepatocellular carcinoma (HCC).. Journal of Clinical Oncology. 35(15_suppl). e15677–e15677. 4 indexed citations
5.
Hunter, K.U. & Shruti Jolly. (2013). Clinical review of physical activity and functional considerations in head and neck cancer patients. Supportive Care in Cancer. 21(5). 1475–1479. 22 indexed citations
6.
Hunter, K.U., Laura L. Fernandes, K.A. Vineberg, et al.. (2013). Parotid Glands Dose–Effect Relationships Based on Their Actually Delivered Doses: Implications for Adaptive Replanning in Radiation Therapy of Head-and-Neck Cancer. International Journal of Radiation Oncology*Biology*Physics. 87(4). 676–682. 57 indexed citations
7.
Hunter, K.U., Teresa Lyden, Marc J. Haxer, et al.. (2013). Aspiration pneumonia after chemo–intensity‐modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia‐related predictors. Head & Neck. 36(1). 120–125. 85 indexed citations
8.
Hunter, K.U., Francis P. Worden, Carol R. Bradford, et al.. (2013). Neck spasm after chemoradiotherapy for head and neck cancer: Natural history and dosimetric correlates. Head & Neck. 36(2). 176–180. 8 indexed citations
9.
Hunter, K.U., et al.. (2013). Biliary Stricture After Radiation Therapy for Hepatocellular Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 87(2). S324–S324. 1 indexed citations
10.
Hunter, K.U., Matthew J. Schipper, Felix Y. Feng, et al.. (2012). Toxicities Affecting Quality of Life After Chemo-IMRT of Oropharyngeal Cancer: Prospective Study of Patient-Reported, Observer-Rated, and Objective Outcomes. International Journal of Radiation Oncology*Biology*Physics. 85(4). 935–940. 156 indexed citations
11.
Hunter, K.U., et al.. (2012). Aspiration Pneumonia After Chemo-IMRT of Head-and-Neck Cancer and its Clinical and Dysphagia-related Predictors. International Journal of Radiation Oncology*Biology*Physics. 84(3). S468–S469. 1 indexed citations
12.
Hunter, K.U., Feng‐Ming Kong, Indrin J. Chetty, et al.. (2012). Pattern of failure after high-dose thoracic radiation for non-small cell lung cancer: the University of Michigan experience. Journal of Radiation Oncology. 1(3). 267–272. 3 indexed citations
13.
Hunter, K.U., et al.. (2012). The Effect of Differences in Planned and Delivered Parotid Doses on Salivary Output. International Journal of Radiation Oncology*Biology*Physics. 84(3). S206–S206.
14.
Hunter, K.U., Felix Y. Feng, Kent A. Griffith, et al.. (2011). Radiation Therapy With Full-Dose Gemcitabine and Oxaliplatin for Unresectable Pancreatic Cancer. International Journal of Radiation Oncology*Biology*Physics. 83(3). 921–926. 4 indexed citations
15.
Hunter, K.U. & Avraham Eisbruch. (2011). Advances in Imaging. The Cancer Journal. 17(3). 151–154. 4 indexed citations
17.
Hunter, K.U., Chester K. Yarbrough, & Joseph D. Ciacci. (2010). Gene- and Cell-Based Approaches for Neurodegenerative Disease. Advances in experimental medicine and biology. 671. 117–130. 8 indexed citations
18.
Hunter, K.U., Chester K. Yarbrough, & Joseph D. Ciacci. (2010). Stem Cells in the Treatment of Stroke. Advances in experimental medicine and biology. 105–116. 7 indexed citations
19.
Rusthoven, Kyle E., et al.. (2006). 1092. International Journal of Radiation Oncology*Biology*Physics. 66(3). S183–S183. 1 indexed citations
20.
Denham, James W., Michael Dally, K.U. Hunter, et al.. (1993). Objective decision-making following a portal film: The results of a pilot study. International Journal of Radiation Oncology*Biology*Physics. 26(5). 869–876. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026